Mazher Mohammed1, Dominique N Johnson2, Lei A Wang1, Scott W Harden1, Wanhui Sheng1, Eliot A Spector1, Khalid Elsaafien1, Michael Bader3,4,5,6, U Muscha Steckelings7, Karen A Scott1, Charles J Frazier1,8,9, Colin Sumners2,8,9, Eric G Krause1,8,9, Annette D de Kloet2,8,9. 1. Department of Pharmacodynamics, University of Florida College of Pharmacy, 1345 Center Dr. JHMHC Room P1-20, Gainesville, FL 32610, USA. 2. Department of Physiology and Functional Genomics, University of Florida College of Medicine, 1345 Center Drive, Room M552, Gainesville, FL 32610-0274, USA. 3. Max-Delbrück Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13125 Berlin-Buch, Germany. 4. University of Lübeck, Institute for Biology, Ratzeburger Allee 160, 23562 Lübeck, Germany. 5. Charité University Medicine, Charitéplatz 1, 10117 Berlin, Germany. 6. German Center for Cardiovascular Research DZHK-Geschäftsstelle, Potsdamer Str. 58, 10785 Berlin, Germany. 7. Department of Cardiovascular & Renal Research, Institute of Molecular Medicine, University of Southern Denmark, J.B. Winsløws Vej 21-25, Odense C - DK-5000, Denmark. 8. Center for Integrative Cardiovascular and Metabolic Diseases, University of Florida, 1149 Newell Dr. Gainesville, FL 32610, USA. 9. Evelyn F. and William L. McKnight Brain Institute, University of Florida, 1149 Newell Dr. Gainesville, FL 32610L, USA.
Abstract
AIMS: These studies evaluate whether angiotensin type-2 receptors (AT2Rs) that are expressed on γ-aminobutyric acid (GABA) neurons in the nucleus of the solitary tract (NTS) represent a novel endogenous blood pressure-lowering mechanism. METHODS AND RESULTS: Experiments combined advanced genetic and neuroanatomical techniques, pharmacology, electrophysiology, and optogenetics in mice to define the structure and cardiovascular-related function of NTS neurons that contain AT2R. Using mice with Cre-recombinase directed to the AT2R gene, we discovered that optogenetic stimulation of AT2R-expressing neurons in the NTS increases GABA release and blood pressure. To evaluate the role of the receptor, per se, in cardiovascular regulation, we chronically delivered C21, a selective AT2R agonist, into the brains of normotensive mice and found that central AT2R activation reduces GABA-related gene expression and blunts the pressor responses induced by optogenetic excitation of NTS AT2R neurons. Next, using in situ hybridization, we found that the levels of Agtr2 mRNAs in GABAergic NTS neurons rise during experimentally induced hypertension, and we hypothesized that this increased expression may be exploited to ameliorate the disease. Consistent with this, final experiments revealed that central administration of C21 attenuates hypertension, an effect that is abolished in mice lacking AT2R in GABAergic NTS neurons. CONCLUSION: These studies unveil novel hindbrain circuits that maintain arterial blood pressure, and reveal a specific population of AT2R that can be engaged to alleviate hypertension. The implication is that these discrete receptors may serve as an access point for activating an endogenous depressor circuit. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: These studies evaluate whether angiotensin type-2 receptors (AT2Rs) that are expressed on γ-aminobutyric acid (GABA) neurons in the nucleus of the solitary tract (NTS) represent a novel endogenous blood pressure-lowering mechanism. METHODS AND RESULTS: Experiments combined advanced genetic and neuroanatomical techniques, pharmacology, electrophysiology, and optogenetics in mice to define the structure and cardiovascular-related function of NTS neurons that contain AT2R. Using mice with Cre-recombinase directed to the AT2R gene, we discovered that optogenetic stimulation of AT2R-expressing neurons in the NTS increases GABA release and blood pressure. To evaluate the role of the receptor, per se, in cardiovascular regulation, we chronically delivered C21, a selective AT2R agonist, into the brains of normotensive mice and found that central AT2R activation reduces GABA-related gene expression and blunts the pressor responses induced by optogenetic excitation of NTS AT2R neurons. Next, using in situ hybridization, we found that the levels of Agtr2 mRNAs in GABAergic NTS neurons rise during experimentally induced hypertension, and we hypothesized that this increased expression may be exploited to ameliorate the disease. Consistent with this, final experiments revealed that central administration of C21 attenuates hypertension, an effect that is abolished in mice lacking AT2R in GABAergic NTS neurons. CONCLUSION: These studies unveil novel hindbrain circuits that maintain arterial blood pressure, and reveal a specific population of AT2R that can be engaged to alleviate hypertension. The implication is that these discrete receptors may serve as an access point for activating an endogenous depressor circuit. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Jason P Joseph; Adam P Mecca; Robert W Regenhardt; Douglas M Bennion; Vermali Rodríguez; Fiona Desland; Neal A Patel; David J Pioquinto; Thomas Unger; Michael J Katovich; U Muscha Steckelings; Colin Sumners Journal: Neuropharmacology Date: 2014-02-06 Impact factor: 5.250
Authors: Nikola Jancovski; David A Carter; Angela A Connelly; Elyse Stevens; Jaspreet K Bassi; Clement Menuet; Andrew M Allen Journal: Exp Physiol Date: 2014-09-18 Impact factor: 2.969
Authors: Keith C Ferdinand; Fabrice Balavoine; Bruno Besse; Henry R Black; Stephanie Desbrandes; Howard C Dittrich; Shawna D Nesbitt Journal: Circulation Date: 2019-04-24 Impact factor: 29.690
Authors: Annette D de Kloet; Soledad Pitra; Lei Wang; Helmut Hiller; David J Pioquinto; Justin A Smith; Colin Sumners; Javier E Stern; Eric G Krause Journal: Endocrinology Date: 2016-06-06 Impact factor: 4.736
Authors: Vanessa Oliveira; John J Reho; Kirthikaa Balapattabi; McKenzie L Ritter; Natalia M Mathieu; Megan A Opichka; Ko-Ting Lu; Connie C Grobe; Sebastião D Silva; Kelsey K Wackman; Pablo Nakagawa; Jeffrey L Segar; Curt D Sigmund; Justin L Grobe Journal: Am J Physiol Regul Integr Comp Physiol Date: 2022-07-11 Impact factor: 3.210
Authors: U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners Journal: Pharmacol Rev Date: 2022-10 Impact factor: 18.923
Authors: Khalid Elsaafien; Scott W Harden; Dominique N Johnson; Aecha K Kimball; Wanhui Sheng; Justin A Smith; Karen A Scott; Charles J Frazier; Annette D de Kloet; Eric G Krause Journal: Front Physiol Date: 2022-03-24 Impact factor: 4.755